0.11 (-%)
As of Nov 22, 2024
Source:
Eyenovia, Inc is a pre-commercial ophthalmic technology company developing the Optejet delivery system both for use in combination with our own drug-device therapeutics and for out-licensing for use in combination with therapeutics for additional indications. Our aim is to improve the delivery of topical ophthalmic medication through the ergonomic design of the Optejet which facilitates ease-of-use and delivery of more physiologically appropriate medication volume, with the goal to reduce side effects and improve tolerability, and introduce digital health technology to improve therapy compliance and ultimately medical outcomes.
Country | United States |
Headquarters | new york, new york |
Phone Number | 813-766-9539 |
Industry | manufacturing |
CEO | Michael Rowe |
Website | www.eyenovia.com |